3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Thoracic
1
Other solid neoplasm
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Pancreatic Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Interventions
Cyclophosphamide
22
Peripheral Blood Stem Cell Transplantation
21
fludarabine phosphate
19
Antilymphocyte Serum
17
Tacrolimus
15
Busulfan
15
Mycophenolic Acid
12
Cyclosporine
12
Methotrexate
11
Whole-Body Irradiation
9
Methylprednisolone
9
Filgrastim
9
Melphalan
8
Sirolimus
6
Radiotherapy
6
Psychiatric Rehabilitation
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
sargramostim
4
Flow Cytometry
4
Polymerase Chain Reaction
3
Early Intervention, Educational
3
Thiotepa
2
Specimen Handling
2
Rituximab
2
Ondansetron
2
Nivolumab
2
Moxifloxacin
2
Morphine
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
bemcentinib
×
Dermatologic
×
Clear all
NCT06469138
2025-01-29
8479217
BerGenBio ASA
Phase 1
Completed
6 enrolled
17 charts